| Terminated | 2/3 | 202 | Europe, Canada, US, RoW | AV-101, Placebo | Aerovate Therapeutics, Aerovate Therapeutics, Inc. | Pulmonary Arterial Hypertension | 08/24 | 08/24 | | |
NCT03409588: Treatment of Exercise-Induced Pulmonary Vascular Dysfunction After Pulmonary Thromboendarterectomy or Balloon Pulmonary Angioplasty |
|
|
| Recruiting | 2 | 20 | US | Adempas, Riociguat | University of Colorado, Denver, Bayer | Chronic Thromboembolic Disease (CTED), Exercise Intolerance Post PEA Surgery | 12/24 | 12/24 | | |
| Recruiting | N/A | 10000 | US | | Cure HHT, Augusta University, The Cleveland Clinic, Mayo Clinic, Massachusetts General Hospital, Columbia University, Oregon Health and Science University, University of California, Los Angeles, University of California, San Francisco, University of Colorado, Denver, University of North Carolina, Chapel Hill, University of Pennsylvania, University of Texas, University of Utah, Washington University School of Medicine, Yale University, Health Resources and Services Administration (HRSA), Children's Hospital of Philadelphia | Hereditary Hemorrhagic Telangiectasia, Arteriovenous Malformations, Telangiectasia, Epistaxis, GastroIntestinal Bleeding, Cerebral Arteriovenous Malformations, Vascular Malformation | 11/33 | 11/33 | | |
| Recruiting | N/A | 3000 | US | | Pulmonary Hypertension Association, Inc., University of Washington, the Collaborative Health Studies Coordinating Center | Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Hypertension | 10/25 | 10/25 | | |
